1. Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents
   Shengzheng Wang et al, 2015, J. Med. Chem. CrossRef
2. The Zuo Jin Wan Formula Induces Mitochondrial Apoptosis of Cisplatin-Resistant Gastric Cancer Cells via Cofilin-1
   Qing-Feng Tang et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells
   ZHENZHEN WEN et al, 2015 CrossRef
4. Evodiamine inhibits PDGF-BB-induced proliferation of rat vascular smooth muscle cells through the suppression of cell cycle progression and oxidative stress
   Xie Ge et al, 2016 CrossRef
5. Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells
   Yuxin Chen et al, 2017 CrossRef
6. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma
   Fan Yang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
7. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway
   Lijun Ji et al, 2018, Molecules CrossRef
8. Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives
   Xu Hu et al, 2018, IJMS CrossRef
9. Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells
   Zhang-Feng Zhong et al, 2015, Sci Rep CrossRef
10. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
    Weixiao An et al, 2019, Front. Pharmacol. CrossRef
11. Emerging Alkaloids Against Cancer: A Peep into Factors, Regulation, and Molecular Mechanisms
    Priya Katyal et al, 2019 CrossRef
12. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
    Chunshu Fang et al, 2014, PLoS ONE CrossRef
13. Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
    Yu-Chieh Lee et al, 2015, PLoS ONE CrossRef
14. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways
    Li Yang et al, 2015, Oncotarget CrossRef
15. Rutaecarpine Derivative Cpd-6c Alleviates Acute Kidney Injury by Targeting PDE4B, a Key Enzyme Mediating inflammation in Cisplatin Nephropathy
    Xue-qi Liu et al, 2020, Biochemical Pharmacology CrossRef
16. Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
    Qiang Sun et al, 2020, Journal of Ethnopharmacology CrossRef
17. Design, synthesis, and biological evaluation of 3′,4′,5′‐trimethoxy evodiamine derivatives as potential antitumor agents
    Yijiao Peng et al, 2021, Drug Dev Res CrossRef
18. Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: Focus on its anti-cancer activity and bioavailability (Review).
    Chaodan Luo et al, 2021, Exp Ther Med CrossRef
19. Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway
    Ruichuang Yang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
20. Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents
    Xiangyong Hao et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
21. Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents
    Fang Lei et al, 2022, J. Med. Chem. CrossRef
22. Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy
    Ziyi Liang et al, 2022, European Journal of Medicinal Chemistry CrossRef
23. Induction of Apoptosis and Effect on the FAK/AKT/mTOR Signal Pathway by Evodiamine in Gastric Cancer Cells
    Ji Yeong Yang et al, 2022, CIMB CrossRef
24. Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study
    Jingli Liu et al, 2022, IJMS CrossRef
25. Effect of Evodiamine on Cancer Metabolism of Liver Tumor Through Met/EGFR and HIF Pathways
    Haiyan Du et al, 2022, SSRN Journal CrossRef
26. N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents
    Jiedan Deng et al, 2023, European Journal of Medicinal Chemistry CrossRef
27. Major Indole Alkaloids in Evodia Rutaecarpa: The Latest Insights and Review of Their Impact on Gastrointestinal Diseases
    Liulin Chen et al, 2023, Biomedicine & Pharmacotherapy CrossRef
28. Comprehensive Analysis of 11 Species of Euodia (Rutaceae) by Untargeted LC-IT-TOF/MS Metabolomics and In Vitro Functional Methods
    Xuhong Yong et al, 2024, Molecules CrossRef
29. Experimental and computational study on anti-gastric cancer activity and mechanism of evodiamine derivatives
    Jingli Liu et al, 2024, Front. Pharmacol. CrossRef
30. Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway
    Che-Yuan Hu et al, 2017, Molecules CrossRef
31. Progress on the effects and underlying mechanisms of evodiamine in digestive system diseases, and its toxicity: A systematic review and meta-analysis.
    Zubing Zhou et al, 2024, Phytomedicine CrossRef
32. Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa
    Longfei Lin et al, 2024, IJN CrossRef